242 related articles for article (PubMed ID: 6095882)
1. Activity of some antibiotics against Pseudomonas aeruginosa strains isolated from cancerous patients.
Del Piano M; Nicosia R; La Palombara P; Chiarini F
Boll Ist Sieroter Milan; 1984 Jul; 63(3):181-7. PubMed ID: 6095882
[TBL] [Abstract][Full Text] [Related]
2. [In vitro comparative activity of 4 beta-lactams against Pseudomonas aeruginosa. Role of cefoperazone].
Joly-Guillou ML; Bergogne-Berezin E; Verin-Prevost C
Pathol Biol (Paris); 1984 May; 32(5):408-11. PubMed ID: 6429612
[TBL] [Abstract][Full Text] [Related]
3. [Sensitivity to antibiotics of Pseudomonas aeruginosa isolated from patients in the years 1986-1988].
Gościniak G; Dolna I; Ruczkowska J; Fleischer M
Wiad Lek; 1989 Oct 1-Nov 1; 42(19-21):1028-32. PubMed ID: 2517806
[TBL] [Abstract][Full Text] [Related]
4. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
Thabaut A; Meyran M; Huerre M
Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of susceptibility of Pseudomonas aeruginosa isolated from a burn ward to antibiotics in vitro].
Zhang YH; Deng SL; Liu JW
Zhonghua Shao Shang Za Zhi; 2005 Apr; 21(2):104-6. PubMed ID: 15938955
[TBL] [Abstract][Full Text] [Related]
6. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
Ciofu O; Giwercman B; Pedersen SS; Høiby N
APMIS; 1994 Sep; 102(9):674-80. PubMed ID: 7946270
[TBL] [Abstract][Full Text] [Related]
7. [Cefoperazone, cefsulodin and ceftazidime--3 cephalosporins active against Pseudomonas in comparison with their monobactam analogs].
Baumgärtner M
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Apr; 254(2):253-60. PubMed ID: 6326420
[TBL] [Abstract][Full Text] [Related]
8. Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
Prince AS; Neu HC
Antimicrob Agents Chemother; 1981 Oct; 20(4):545-6. PubMed ID: 6282199
[TBL] [Abstract][Full Text] [Related]
9. The patterns and transmissibility of antibiotic resistance among clinical strains of Pseudomonas aeruginosa.
Palillo ES; Salleh MA
Microbiol Immunol; 1992; 36(11):1195-200. PubMed ID: 1491621
[TBL] [Abstract][Full Text] [Related]
10. [Application of a millipore membrane transfer method to the study of the activity of 4 beta-lactams on Pseudomonas aeruginosa].
Denis C; Lesage D; Delisle-Mizon F; Vergez P; Daguet GL
Pathol Biol (Paris); 1984 May; 32(5):415-20. PubMed ID: 6429614
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of ceftazidime and other antipseudomonal antibiotics against mucoid strains of pseudomonas aeruginosa.
Christie CD; Baltimore RS
West Indian Med J; 1988 Jun; 37(2):87-91. PubMed ID: 3146165
[No Abstract] [Full Text] [Related]
12. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.
Venditti M; Brandimarte C; Santini C; Valente B; Martino P; Serra P
Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625
[TBL] [Abstract][Full Text] [Related]
13. Comparative susceptibility studies of clinically isolated Pseudomonas aeruginosa, Escherichia coli and Klebsiella spp to cefoperazone and cefotaxime.
Lee YH; Hussain ZA; Choong FP
J Hyg Epidemiol Microbiol Immunol; 1990; 34(3):299-303. PubMed ID: 2125616
[TBL] [Abstract][Full Text] [Related]
14. [Pseudomonas aeruginosa: acquired in vitro resistance to beta-lactams].
Thabaut A; Meyran M
Pathol Biol (Paris); 1983 May; 31(5):387-91. PubMed ID: 6413939
[TBL] [Abstract][Full Text] [Related]
15. Emerging microorganisms in cystic fibrosis.
Fabbri A; Tacchella A; Manno G; Viscoli C; Palmero C; Gargani GF
Chemioterapia; 1987 Feb; 6(1):32-7. PubMed ID: 3103930
[TBL] [Abstract][Full Text] [Related]
16. Development of resistance and cross-resistance in Pseudomonas aeruginosa exposed to subinhibitory antibiotic concentrations.
Wu YL; Scott EM; Po AL; Tariq VN
APMIS; 1999 Jun; 107(6):585-92. PubMed ID: 10379686
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
Pruekprasert P; Tunyapanit W
Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
[TBL] [Abstract][Full Text] [Related]
18. [Comparative activity of dibekacin and several cephalosporins on Pseudomonas aeruginosa].
Carlone NA; Cuffini AM; Forno-Pizzoglio M; Aragno M
G Batteriol Virol Immunol; 1983; 76(7-12):246-56. PubMed ID: 6099297
[TBL] [Abstract][Full Text] [Related]
19. [Sensitivity of clinical Ps. aeruginosa strains to antibiotics].
Suiumova AS; Iskhakova KhI; Bazhenov LG
Antibiotiki; 1982 Jun; 27(6):413-6. PubMed ID: 6810753
[TBL] [Abstract][Full Text] [Related]
20. [Comparative in vitro activity of 5 beta-lactams (cefoperazone, cefsulodin, ceftazidime, azthreonam, N-formimidoyl-thienamycin) on 90 strains of Pseudomonas aeruginosa with various levels of resistance to ticarcillin].
Le Noc P; Robert J; Le Noc D
Pathol Biol (Paris); 1984 May; 32(5):404-7. PubMed ID: 6429611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
